nonprofit logo

Ependymoma Research Foundation Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 832956990 ✦ Lexington, MA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Ependymoma Research Foundation Inc?

The Ependymoma Research Foundation Inc, based on the provided information, is a nonprofit organization committed to advancing research in the fight against Ependymoma, a specific type of brain tumor. Their primary objective is to discover an efficient and side-effect-free treatment for this condition. Currently, they are financially backing a significant research project worth $100,000 at the Dana Farber Cancer Institute. This project focuses on a unique protein named Ezhip, which holds potential as a therapeutic target. The foundation's mission is to contribute to the scientific community and ultimately improve the lives of individuals affected by Ependymoma.

Is Ependymoma Research Foundation Inc legitimate?

Ependymoma Research Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Ependymoma Research Foundation Inc submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

What is the mission statement of Ependymoma Research Foundation Inc?

The Ependymoma Research Foundation, in its mission, focuses on supporting scientific research with the primary objective of discovering an effective and side-effect-free treatment for Ependymoma. At present, the organization is funding a significant project worth $100,000 at the Dana Farber Cancer Institute. This project explores a unique protein named Ezhip, which holds potential as a target for potential therapeutic interventions. The foundation's endeavors aim to significantly contribute to the advancement of Ependymoma treatment and ultimately improve the lives of those affected by this condition.

Who is the CEO of Ependymoma Research Foundation Inc?

Jeffrey Clayman is the President of Ependymoma Research Foundation Inc.

What is the revenue of Ependymoma Research Foundation Inc?

Ependymoma Research Foundation Inc's revenue in 2023 was $42,363.

Who are the executives of Ependymoma Research Foundation Inc and what are their salaries?


Here are 4 key members and their salaries:


Jeffrey Clayman (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Samarrah Clayman (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Pietra Check (Clerk)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sandy Smoot (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Where can I find the form 990EZ for Ependymoma Research Foundation Inc?

Ependymoma Research Foundation Inc's most recent form 990EZ was submitted in 2023 and can be accessed here.

Mission Statement of Ependymoma Research Foundation Inc

The Ependymoma Research Foundation, a dedicated organization, focuses on supporting scientific research with the primary objective of discovering an efficient and side-effect-free treatment for Ependymoma. Currently, the foundation is financially backing a substantial project worth $100,000 at the Dana Farber Cancer Institute. This project investigates a distinctive protein named Ezhip, which holds potential as a therapeutic target for Ependymoma. By funding such research, the Ependymoma Research Foundation aims to make significant strides in the fight against this particular type of brain tumor.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




August, 2024

Ependymoma Research Foundation Inc's impact lies in supporting scientific research with the primary aim of discovering an effective and side-effect free treatment for Ependymoma. The organization is currently funding a $100,000 project at the Dana Farber Cancer Institute that focuses on investigating a unique protein called Ezhip, which shows promise as a potential target for therapy. This research has the potential to significantly advance the understanding and treatment of Ependymoma, offering hope to individuals affected by this condition.




This information is meant to be a general summary of Ependymoma Research Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$42,363 (2023)
Expenses
$2,296 (2023)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $120
  • Gross Receipts: $42,363

Assets and Liabilities:

  • Total Assets: $69,267
  • Total Liabilities: $0
  • Net Assets: $69,267

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Principal Officer

Jeffrey Clayman

Main Address

10 FROST ROAD, LEXINGTON, MA, 02420

NTEE Category

Code: H80 - Medical research

If you are a representative of Ependymoma Research Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.